Dr. Pearson is President and CEO of Pearson Pharma Partners. He has had an extensive and successful career, previously serving as Chief Development Officer at Lengo Therapeutics, Vice President of Pharmacokinetics and Drug Metabolism at Amgen, Inc. and Executive Director of Preclinical Drug Metabolism at Merck & Co, Inc.
He has contributed to numerous peer-reviewed publications on drug development, drug metabolism, and drug discovery, and is the editor of the Handbook of Drug Metabolism. He is actively engaged in the discovery and development of new human therapeutics in the fields of oncology and neuroscience to make a dramatic difference to the lives of patients.
Dr. Pearson received his Ph.D. in Pharmaceutical Sciences from Aston University, Birmingham.